86 Stocks Moving In Friday's Mid-Day Session

Gainers

  • iBio, Inc. IBIO shares jumped 206.5% to $2.65 after jumping around 159% on Thursday. iBio disclosed a $100 million mixed securities offering.
  • Ritter Pharmaceuticals Inc RTTR shares jumped 128% to $0.6467 after climbing over 35% on Thursday.
  • Altimmune Inc ALT climbed 125% to $3.96. Altimmune reported completion of first development milestone toward a single-dose intranasal coronavirus vaccine.
  • Dynatronics Corporation DYNT surged 121% to $2.6624 after climbing more than 24% on Thursday.
  • Allied Healthcare Products, Inc. AHPI shares gained 107.5% to $32.20 after climbing around 322% on Thursday. The company manufactures emergency medical supplies and respiratory devices, including 'mass casualty' products, and has attracted investor interest amid the coronavirus outbreak.
  • OpGen, Inc. OPGN shares gained 78.5% to $3.6399 after gaining around 38% on Thursday.
  • Trillium Therapeutics Inc. TRIL shares rose 62.3% to $5.03 in sympathy with Forty Seven after Gilead Sciences approached the company with a takeover offer.
  • Alpha Pro Tech, Ltd. APT jumped 39% to $35.08. Alpha Pro Tech shares jumped around 104% on Thursday after the company announced it has booked $14.1 million in orders for its N-95 face mask since Jan. 27, which it expects will be fulfilled.
  • Novavax, Inc. NVAX rose 38.6% to $16.35 after gaining around 28% on Thursday. Shares of several vaccine companies are trading higher on growing global coronavirus fears.
  • Correvio Pharma Corp CORV jumped 37.7% to $0.42.
  • Titan Pharmaceuticals, Inc. TTNP gained 36% to $0.2860.
  • Cytosorbents Corporation CTSO surged 33% to $6.98. CytoSorbents reported that shipment arrived in designated mainland China hospitals to treat cytokine storm in critically-ill patients with COVID-19 coronavirus infection.
  • Datasea Inc. DTSS gained 32.2% to $2.75.
  • Trinity Biotech plc TRIB rose 30.8% to $1.40 after climbing more than 12% on Thursday.
  • Sangamo Therapeutics Inc SGMO rose 28% to $8.53. Sangamo and Biogen Inc announced a global licensing collaboration agreement for developing and commercializing ST-501 for tautopathies including Alzheimer's disease, ST-502 for synucleinopathies, including Parkinson's disease, a third undisclosed neuromuscular disease target, and upto nine additional undisclosed neurological disease targets. The company also reported better-than-expected Q4 EPS results and sales up from last year.
  • Verastem Inc VSTM jumped 25.4% to $2.3950 after the company announced a strategic direction to accelerate the development of CH5126766 for the treatment of KRAS mutant solid tumors.
  • Vaxart, Inc. VXRT shares rose 23.1% to $3.04 after surging around 50% on Thursday.
  • MDC Partners Inc. MDCA gained 23% to $2.48 after reporting Q4 results.
  • Forty Seven, Inc. FTSV surged 22.5% to $59.77 on reports of a takeover interest. Gilead Sciences, , which is contending with an aging AIDS franchise and a flailing NASH program, has made overtures to Forty Seven, according to a Bloomberg, citing people with knowledge of the information. Gilead reportedly is considering several options, including forging a partnership. The Bloomberg report said Forty Seven had received takeover interest from other companies as well.
  • Lakeland Industries, Inc. LAKE shares rose 22.1% to $24.39 after surging 22.5% on Thursday.
  • COMSCORE, Inc. SCOR rose 21.2% to $3.63 after the company reported better-than-expected Q4 EPS results.
  • Penn Virginia Corporation PVAC surged 20.8% to $14.30 following strong quarterly sales.
  • GenMark Diagnostics, Inc. GNMK gained 19% to $4.305. GenMark diagnostics site showed that company has coronavirus test.
  • Farfetch Limited FTCH surged 17.4% to $11.14 after the company reported better-than-expected Q4 results.
  • Chembio Diagnostics, Inc. CEMI jumped 15.6% to $4.58.
  • Co-Diagnostics, Inc. CODX rose 14.7% to $18.30 after surging over 79% on Thursday. Co-Diagnostics reported a $4.2 million registered direct offering priced at the market at $9 per share on Thursday. Shares of several vaccine companies are trading higher on growing global coronavirus fears.
  • Zynex, Inc. ZYXI gained 14.6% to $13.66 after reporting strong Q4 results.
  • Owens & Minor, Inc. OMI surged 14.4% to $7.01.
  • BOQI International Medical Inc. BIMI rose 13.8% to $4.8001.
  • Nautilus, Inc. NLS surged 12.3% to $3.10.
  • Rayonier Advanced Materials Inc. RYAM jumped 11.7% to $2.30.
  • The Lovesac Company LOVE rose 11.3% to $8.79.
  • Diamond Offshore Drilling, Inc DO gained 11.2% to $2.88 despite market downturn and weakness in oil.
  • Guardion Health Sciences Inc GHSI gained 11.1% to $0.5221.
  • Beyond Air, Inc. XAIR gained 10.9% to $8.11.
  • Surface Oncology, Inc. SURF shares rose 10.9% to $2.9499.
  • Chico's FAS, Inc. CHS climbed 10.8% to $4.0450 despite overall market downturn. The company early Thursday reported better-than-expected Q4 results and raised its quarterly dividend,
  • Spectrum Pharmaceuticals, Inc. SPPI shares gained 10.8% to $2.66 following Q4 results.
  • Briggs & Stratton Corporation BGG jumped 10% to $3.29.
  • RealPage, Inc. RP shares gained 10% to $60.56 following better-than-expected quarterly results.
  • Carrols Restaurant Group, Inc. TAST jumped 9.5% to $4.17.
  • NeoPhotonics Corp NPTN shares rose 8.3% to $6.69 after the company reported better-than-expected Q4 sales results. The company also issued Q1 EPS guidance above estimates.
  • Trade Desk Inc TTD rose 7.5% to $268.80 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY20 sales guidance above estimates.


Check out these big penny stock gainers and losers

Losers

  • Gulfport Energy Corporation GPOR shares dipped 44.4% to $0.5002 after reporting downbeat Q4 results.
  • Tellurian Inc. TELL tumbled 40.1% to $2.20 as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.
  • Glaukos Corporation GKOS shares fell 30% to $43.05 after the company Q4 results. JP Morgan downgraded Glaukos from Overweight to Neutral and lowered the price target from $65 to $55.
  • Tonix Pharmaceuticals Holding Corp TNXP fell 29.8% to $1.2150. Tonix Pharmaceuticals priced its $16 million common stock offering at $1.10 per share.
  • Big Lots, Inc. BIG tumbled 29.3% to $15.87 after the company reported worse-than-expected Q4 results. The company also issued Q1 and FY20 earnings guidance below estimates. JP Morgan downgraded Big Lots from Neutral to Underweight and lowered the price target from $31 to $14.
  • Novan Inc NOVN shares dipped 27.8% to $0.2455 after the company priced its 18.3 million share and warrant public offering.
  • China Online Education Group COE fell 23.8% to $22.34 after dropping 15.8% on Thursday.
  • Summit Midstream Partners, LP SMLP dropped 22.8% to $1.76 after reporting Q4 results.
  • Vir Biotechnology, Inc. VIR fell 21.6% to $47.22 after gaining more than 72% on Thursday.
  • SemiLEDs Corporation LEDS shares declined 18.8% to $2.08.
  • Beyond Meat, Inc. BYND shares dipped 18.6% to $86.36. Beyond Meat reported weaker-than-expected earnings for its fourth quarter, while sales exceeded views.
  • Wayfair Inc W fell 17% to $58.44 after reporting wider-than-expected Q4 loss.
  • Metalla Royalty & Streaming Ltd. MTA dipped 16.4% to $3.96.
  • Taronis Technologies Inc TRNX fell 16% to $0.2941.
  • Eventbrite, Inc. EB dropped 15.8% to $14.34 following Q4 results. RBC Capital downgraded Eventbrite from Outperform to Sector Perform.
  • Codexis, Inc. CDXS fell 15% to $11.28 following Q4 results.
  • Equinox Gold Corp. EQX fell 14.5% to $6.91 after dropping 10% on Thursday.
  • SG Blocks, Inc. SGBX shares dipped 14.5% to $1.82.
  • Addus HomeCare Corporation ADUS shares declined 14.4% to $76.64.
  • Iterum Therapeutics plc ITRM fell 14.2% to $2.4625.
  • OptimizeRx Corporation OPRX tumbled 14.2% to $8.61 after reporting Q4 results.
  • Harmony Gold Mining Company Limited HMY fell 13.6% to $3.2725.
  • Mesoblast Limited MESO fell 12.5% to $7.00.
  • Americas Gold and Silver Corporation USAS shares declined 12% to $2.20.
  • Switch, Inc. SWCH fell 11.9% to $14.16 following Q4 results.
  • CytomX Therapeutics, Inc. CTMX shares declined 11.6% to $6.30. Nomura lowerd the price target on CytomX Therapeutics from $22 to $15.
  • Sandstorm Gold Ltd. SAND dipped 11.5% to $6.02.
  • Protalix BioTherapeutics, Inc. PLX shares dipped 11.4% to $3.34 after rising 6.2% on Thursday.
  • Great Elm Capital Corporation GECC tumbled 11.2% to $6.58.
  • Intevac, Inc. IVAC fell 10.8% to $5.42.
  • iQIYI, Inc. IQ dipped 10.5% to $21.86 after the company reported Q4 earnings results.
  • Gannett Co., Inc. GCI fell 10.3% to $4.3050 as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.
  • Aethlon Medical, Inc. . AEMD fell 10% to $2.6998 after gaining more than 58% on Thursday.
  • Hamilton Lane Incorporated HLNE dropped 10% to $57.95.
  • Tocagen Inc TOCA fell 10% to $1.45 after the company reported Q4 results.
  • VMware, Inc. VMW fell 7.7% to $125.23 after the company reported worse-than-expected Q4 EPS results.
  • Mechel PAO MTL fell 7.5% to $2.5150 after declining over 11% on Thursday.
  • Anheuser Busch Inbev NV BUD fell 7.4% to $55.73 after Bryan Garnier downgraded the stock from Buy to Neutral.
  • Innate Pharma S.A. IPHA fell 7.3% to $7.02.
  • Kirkland Lake Gold Ltd. KL dipped 7.3% to $31.33 after dropping more than 7% on Thursday.
  • TRACON Pharmaceuticals Inc TCON fell 6.8% to $2.75 after the company reported Q4 results.
  • SmileDirectClub, Inc. SDC fell 6.5% to $7.30.
  • Dell Technologies Inc DELL fell 6% to $40.99 following Q4 results.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsIntraday UpdateMarketsMoversTrading IdeasHealth CareMid-Day MoversPharmaceuticalsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!